Julie Le Merrer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Julie Le Merrer

Showing results (21-30 of 33) with videos related to

Pageof 4

Sort By:

Biological Psychiatry|July 20, 2015

Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid AntagonistAura C Meirsman, Julie Le Merrer, Lucie P Pellissier, et al.

Biological Psychiatry|May 19, 2023

Balance Between Projecting Neuronal Populations of the Nucleus Accumbens Controls Social Behavior in MiceJulie Le Merrer, Bérangère Detraux, Jorge Gandía, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 14, 2022

Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autismCécile Derieux, Audrey Léauté, Agathe Brugoux, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2024

Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context mattersFani Pantouli, Camille N Pujol, Cécile Derieux, et al.

Elife|February 1, 2020

The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRsThibaut Laboute, Jorge Gandía, Lucie P Pellissier, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2012

In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profileLauren Faget, Eric Erbs, Julie Le Merrer, et al.

Nature Communications|January 26, 2026

Targeting mGlyR with nanobodies for depressionThibaut Laboute, Stefano Zucca, Omar K Sial, et al.

Journal of Medicinal Chemistry|September 11, 2018

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of AutismMarie-Céline Frantz, Lucie P Pellissier, Elsa Pflimlin, et al.

Nature Chemical Biology|June 10, 2022

Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brainJiyong Meng, Chanjuan Xu, Pierre-André Lafon, et al.

Journal of Hazardous Materials|May 22, 2025

Lifelong exposure to polystyrene-nanoplastics induces an attention-deficit hyperactivity disorder-like phenotype and impairs brain aging in miceAnaïs N Vignon, Gaëlle Dudon, Giulia Oliva, et al.

Pageof 4

Search research articles

Showing results (21-30 of 33) with videos related to

Sort By:

Pageof 4

Biological Psychiatry|July 20, 2015

Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid AntagonistAura C Meirsman, Julie Le Merrer, Lucie P Pellissier, et al.

Biological Psychiatry|May 19, 2023

Balance Between Projecting Neuronal Populations of the Nucleus Accumbens Controls Social Behavior in MiceJulie Le Merrer, Bérangère Detraux, Jorge Gandía, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 14, 2022

Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autismCécile Derieux, Audrey Léauté, Agathe Brugoux, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2024

Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context mattersFani Pantouli, Camille N Pujol, Cécile Derieux, et al.

Elife|February 1, 2020

The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRsThibaut Laboute, Jorge Gandía, Lucie P Pellissier, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2012

In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profileLauren Faget, Eric Erbs, Julie Le Merrer, et al.

Nature Communications|January 26, 2026

Targeting mGlyR with nanobodies for depressionThibaut Laboute, Stefano Zucca, Omar K Sial, et al.

Journal of Medicinal Chemistry|September 11, 2018

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of AutismMarie-Céline Frantz, Lucie P Pellissier, Elsa Pflimlin, et al.

Nature Chemical Biology|June 10, 2022

Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brainJiyong Meng, Chanjuan Xu, Pierre-André Lafon, et al.

Journal of Hazardous Materials|May 22, 2025

Lifelong exposure to polystyrene-nanoplastics induces an attention-deficit hyperactivity disorder-like phenotype and impairs brain aging in miceAnaïs N Vignon, Gaëlle Dudon, Giulia Oliva, et al.

Pageof 4